Express Scripts Announces New Formulary Design Option
This week, Express Scripts announced that it would provide clients with the ability to opt for its new National Preferred Flex Formulary Design. As opposed to favoring drugs that garner the most rebate dollars, the new benefit design intends to favor drugs that have lower list prices to begin with.
CSRO Hosts State Society Leaders at the ACR
On Monday, October 22nd, CSRO hosted a breakfast for state rheumatology society leaders present at the ACR. Attendees had the opportunity to learn more about emergent patient access issues, CSRO’s plans for 2019, and hear from a speaker who discussed implementation and compliance issues with existing patient access laws.
CSRO Discusses New Drug Payment Model with Key Agency Officials
Last week, CSRO’s Past President and National Advocacy Chair, Michael Schweitz, MD, participated in one-on-one discussions with Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma and Special Advisor to the Administrator Jeet Guram, MD, to discuss details about the Trump Administration’s potential International Pricing Index Model for Medicare Part B Drugs.